A Report on Primary Pancreatic Malignancy and Clear Cell Adenocarcinoma

Trossberg Wilson^*
*Correspondence: Trossberg Wilson, Department of Medicine, University of Pennsylvania, Pennsylvania, USA, Email:

Introduction

The most frequent cause of acute pancreatitis is gallstones. More than 80% of cases are settled within a few days. The diagnosis is based on transabdominal ultrasonography findings, discomfort in the upper abdomen, and elevated lipase and/or amylase levels. Treatment must include early, intensive hydration, pain control, nutritional support, and progression monitoring. There is a significant rate of mortality, recurrence, and development of chronic pancreatitis linked with hypovolemia, systemic inflammatory response, pancreatic necrosis, and organ failure (CP). Genetic predisposition and repetitive damage may be necessary for CP to develop. Controlling risk variables, especially alcohol consumption, is crucial, as is managing pain, exocrine, and endocrine symptoms [1].

Description

Ductal adenocarcinoma, the most frequent primary tumour diagnosed in pancreatic cancer, has a dismal prognosis. Rarely associated with pancreatic cancer, clear cell carcinoma more frequently occurs in conjunction with malignancies of the kidney, ovary, or bladder. According to the WHO classification, primary clear cell adenocarcinoma of the pancreas is a rare "miscellaneous" cancer with only a few cases documented in the literature thus far. Discomfort in the stomach due to pancreatitis. After that, an abdominal computed tomography showed a necrotic pancreatic tumour with hepatic metastases. A diagnosis of pancreatic clear cell adenocarcinoma was made following additional histology and immunehistochemical tests. To begin a lowdose nab-paclitaxel and gemcitabine treatment, the patient was sent home [2].

A quick onset of acute pancreatitis is a sign of pancreatic cancer. This study was out to identify the risk of pancreatic cancer after an incident of acute pancreatitis. The proportion of pancreatic cancer cases per 1,000 personyears. The number of cases of pancreatic cancer per 1000 person-years in those who did not have chronic pancreatitis. As a result, people with chronic pancreatitis had a nearly 9 times higher risk of developing pancreatic cancer [3].

Primary clear cell carcinoma of the pancreas is not very prevalent. Patients having a mass in the distal body and tail of the pancreas. On him, a distal pancreatectomy was done. Histopathology revealed abundant transparent cytoplasm and distinct cell boundaries in tumour cells. Neoplastic cells responded to antibodies against cytokeratin-7, but not to those against hepatocyte nuclear factor-1, carbonic anhydrase 9, synaptophysin, or chromogranin A. Later on, it was determined that the patient had a primary clear cell pancreatic cancer. We have never before encountered it. The literature on this tumour has been updated, and this is a rare case report [4].

It seldom happens for cancer to spread to the pancreas. One of the potential sites for pancreatic metastases is renal cell carcinoma. Renal cell cancer typically develops late metastases that only affect the pancreas, which suggests that renal cell carcinoma has a special role among primary metastases that affect the pancreas [5]. When pancreatic ductal adenocarcinoma is borderline resectable, total pancreatectomy is performed after treatment with folic acid, fluorouracil, irinotecan, and oxaliplatin for renal cell carcinoma. Two clear-cell renal cell carcinoma metachronous metastases that developed simultaneously and geographically with pancreatic ductal adenocarcinoma were also discovered in the pancreatic body.

Conclusion

Cancer of the renal cells Rarely, decades after the initial renal cell carcinoma diagnosis, do pancreatic metastases develop. Pancreatic ductal adenocarcinoma and metastases of renal cell carcinoma are substantially less prevalent. However, it is important for clinicians, radiologists, and pathologists to consider the possibility. Further research should be done on the role of renal cell carcinoma as a site of pancreatic metastasis.

Conflicts of Interest

The authors declare no conflict of interest.

References

1. Walling, Anne, and Robert Freelove. “Pancreatitis and pancreatic cancer.” Prim Care 44(2017):609-620.

Google Scholar, Crossref, Indexed at

2. O'Neill, Robert S., Lyn L. Lam, Parthsinh Solanki, and Robyn Levingston, et al. “Clear cell adenocarcinoma presenting as acute pancreatitis: A rare form of primary pancreatic malignancy.” Cancer Rep 3(2020):e1273.

Google Scholar, Crossref, Indexed at

3. Rijkers, Anton P., Olaf J. Bakker, Usama Ahmed Ali, and Julia CJP Hagenaars, et al. “Risk of pancreatic cancer after a primary episode of acute pancreatitis.” Pancreas 46(2017):1018-1022.

Google Scholar, Crossref, Indexed at

4. Sun, Pi-Jiang, Yan-Hua Yu, and Xi-Jun Cui. “Primary clear cell adenocarcinoma of the pancreas: a case report and literature update.” Onco Targets Ther 9(1995):686-691.

Google Scholar, Crossref, Indexed at

5. Haeberle, Lena, Melanie Busch, Julian Kirchner, and Georg Fluegen, et al. “Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: A case report.” J Med Case Rep 15(2021):314.

Google Scholar, Crossref, Indexed at